|
|
|
| |
|
|
| |
The latest COVID-19 news from News Medical |
|
|
|
 | | |  CDC tracks SARS-CoV-2 BA.3.2 global rise and finds early signals in U.S. wastewater CDC surveillance shows that the highly divergent SARS-CoV-2 variant BA.3.2 spread to at least 23 countries and was detected in U.S. travelers, patients, airplane wastewater, and wastewater samples across multiple states. The report highlights wastewater and traveler-based genomic surveillance as early warning tools while noting that BA.3.2 has immune-evasion potential but has not rapidly displaced other circulating lineages. | | | | |  Do multi-strain probiotics improve long covid symptoms? Multi-strain probiotics show potential to modulate gut microbiome in long COVID, yet their impact on inflammation and recovery is not statistically significant. | |
|
|
| | | | | A randomized placebo-controlled trial found that fluvoxamine, a low-cost antidepressant, reduced fatigue and improved quality of life in adults with long COVID, offering one of the first evidence-based medication options for this persistent condition. In contrast, metformin did not provide meaningful benefit for established long COVID fatigue, highlighting fluvoxamine as the more promising treatment candidate in this study. | | | | | Global maternal deaths have declined over the past three decades, yet progress has slowed in recent years and remains uneven across countries, according to new Global Burden of Disease (GBD) 2023 research published today in The Lancet Obstetrics, Gynaecology, & Women's Health. | | | | | First systematic review to track long-term trends across pre- and post-pandemic periods finds dramatic rise in screen use among children and adolescents. | |
|
|
|
|
|
|
|
